Journal of VirologyMicrobiologyPeer-reviewed journal article
H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves
Carine K. SouzaiD, Jefferson José da Silva SantosiD, Paola Mercedes BoggiattoiD, Haley M. Sterle, Bailey L. ArrudaiD, Mitchell V. PalmeriD, Alessandra Campos, Jiaojiao LiuiD, Naiqing YeiD, Drew WeissmaniD, Scott E. HensleyiD, Amy L. Vincent BakeriD
Abstract
Highly pathogenic avian influenza (HPAI) clade 2.3.4.4b H5N1 is circulating widely in lactating cows in the United States. Due to the critical need for intervention strategies for this outbreak, we evaluated antibody and cellular immune responses of a clade 2.3.4.4b H5 mRNA-LNP vaccine in calves. We found that the H5 mRNA-LNP vaccine induced a robust antibody and CD8+ T cellular-mediated immune response and conferred protection against clade 2.3.4.4b H5N1 infection.
- organism: chicken / avian
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 9
- FWCI
- 18.45
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evaluation of an H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccine in lactating dairy cows
Jefferson J. S. Santos, Carine K. Souza, … Scott E. Hensley·Nature BiotechnologyPeer-reviewed·Oct 28, 2026
- Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
C. Furey, N. Ye, … S. E. Hensley·bioRxiv·Apr 30, 2023
- Immune History Modifies Disease Severity to HPAI H5N1 Clade 2.3.4.4b Viral Challenge
Pamela H. Brigleb, Bridgett Sharp, … Stacey Schultz‐Cherry·bioRxiv·Oct 23, 2024
- Dual-Route H5N1 Vaccination Induces Systemic and Mucosal Immunity in Murine and Bovine Models
Joshua Wiggins, Adthakorn Madapong, Eric A. Weaver·npj VaccinesPeer-reviewed·Apr 21, 2026
- A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine.
Giovana Ciacci Zanella, Marissa Vincent, … Amy L. Vincent Baker·Journal of VirologyPeer-reviewed·Oct 9, 2026
- Mice immunized with N1 neuraminidase in a single cycle infectious virus or in a recombinant nanoparticle vaccine are protected against lethal challenge with highly pathogenic avian influenza H5N1 influenza
Michael S. Piepenbrink, Ramya S. Barre, … James J. Kobie·bioRxiv·Oct 12, 2026